» Articles » PMID: 22433339

Vasomotor Symptoms and Lipid Profiles in Women Transitioning Through Menopause

Overview
Journal Obstet Gynecol
Date 2012 Mar 22
PMID 22433339
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine associations between vasomotor symptoms and lipids over 8 years, controlling for other cardiovascular risk factors, estradiol, and follicle-stimulating hormone.

Methods: Study of Women's Health Across the Nation participants (N=3,201), aged 42-52 years at entry, completed interviews on frequency of hot flushes and night sweats (none, 1-5 days, 6 days or more, in the past 2 weeks) physical measures (blood pressure, height, weight), and blood draws (low-density lipoprotein [LDL], high-density lipoprotein [HDL], apolipoprotein A-1, apolipoprotein B, lipoprotein[a], triglycerides, serum estradiol, follicle-stimulating hormone) yearly for 8 years. Relations between symptoms and lipids were examined in linear mixed models adjusting for cardiovascular risk factors, medications, and hormones.

Results: Compared with no flushes, experiencing hot flushes was associated with significantly higher LDL (1-5 days: β [standard error]=1.48 [0.47], P<.01; 6 days or more: β [standard error]=2.13 [0.62], P<.001), HDL (1-5 days: β [standard error]=0.30 [0.18]; 6 days or more: β [standard error]=0.77 [0.24], P<.01), apolipoprotein A-1 (1-5 days: β [standard error]=0.92 [0.47], P<.10; 6 days or more: β [standard error]=1.97 [0.62], P<.01), apolipoprotein B (1-5 days: β [standard error]=1.41 [0.41], P<.001; 6 days or more: β [standard error]=2.51 [0.54], P<.001), and triglycerides (1-5 days: percent change [95% confidence interval]=2.91 [1.41-4.43], P<.001; 6 days or more: percent change [95% confidence interval[=5.90 [3.86-7.97], P<.001) in multivariable models. Findings largely persisted adjusting for hormones. Estimated mean differences in lipid levels between hot flushes 6 days or more compared with no days ranged from less than 1 (for HDL) to 10 mg/dL (for triglycerides). Night sweats were similar. Associations were strongest for lean women.

Conclusion: Vasomotor symptoms were associated with higher LDL, HDL, apolipoprotein A-1, apolipoprotein B, and triglycerides. Lipids should be considered in links between hot flushes and cardiovascular risk.

Level Of Evidence: II.

Citing Articles

The influence of habitual physical activity and sedentary behavior on objective and subjective hot flashes at midlife.

Witkowski S, White Q, Shreyer S, Brown D, Sievert L Menopause. 2024; 31(5):381-389.

PMID: 38530999 PMC: 11052676. DOI: 10.1097/GME.0000000000002341.


The relationship between dyslipidemia and menopausal symptoms in Chinese menopausal women: a cross-sectional study.

Hu L, Yu S, Liao Y, Liang W, Yang H, Liu J Arch Womens Ment Health. 2024; 27(6):923-930.

PMID: 38376616 DOI: 10.1007/s00737-024-01436-2.


Interleukin-17, C-reactive protein, Neutrophil-to-Lymphocyte ratio, Lymphocyte-to-Monocyte ratio, and lipid profiles in healthy menopausal women with or without hot flashes: A cross-sectional study.

Didevar N, Rezasoltani P, Pourgholaminejad A, Leyli E, Seyednoori T, Zahiri Sorouri Z PLoS One. 2023; 18(11):e0291804.

PMID: 37992065 PMC: 10664956. DOI: 10.1371/journal.pone.0291804.


Cohort Profile Update: Project Viva mothers.

Rifas-Shiman S, Aris I, Switkowski K, Young J, Fleisch A, James-Todd T Int J Epidemiol. 2023; 52(6):e332-e339.

PMID: 37875013 PMC: 10749767. DOI: 10.1093/ije/dyad137.


Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies.

Thurston R Climacteric. 2023; 27(1):75-80.

PMID: 37577812 PMC: 10843629. DOI: 10.1080/13697137.2023.2196001.


References
1.
Szmuilowicz E, Manson J, Rossouw J, Howard B, Margolis K, Greep N . Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause. 2011; 18(6):603-10. PMC: 3123435. DOI: 10.1097/gme.0b013e3182014849. View

2.
Kubzansky L, Kawachi I, Weiss S, Sparrow D . Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med. 1999; 20(2):47-58. DOI: 10.1007/BF02884448. View

3.
Lett H, Blumenthal J, Babyak M, Sherwood A, Strauman T, Robins C . Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med. 2004; 66(3):305-15. DOI: 10.1097/01.psy.0000126207.43307.c0. View

4.
Gast G, Samsioe G, Grobbee D, Nilsson P, van der Schouw Y . Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women. Maturitas. 2010; 66(3):285-90. DOI: 10.1016/j.maturitas.2010.03.015. View

5.
Woods N, Mitchell E, Smith-DiJulio K . Cortisol levels during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause. 2009; 16(4):708-18. PMC: 2749064. DOI: 10.1097/gme.0b013e318198d6b2. View